Protein–protein interactions (PPIs) are the vital engine of cellular machinery. After virus entry in host cells the global organization of the viral life cycle is strongly regulated by the formation of virus-host protein interactions. With the advent of high-throughput -omics platforms, the mirage to obtain a “high resolution” view of virus–host interactions has come true. In fact, the rapidly expanding approaches of mass spectrometry (MS)-based proteomics in the study of PPIs provide efficient tools to identify a significant number of potential drug targets. Generation of PPIs maps by affinity purification-MS and by the more recent proximity labeling-MS may help to uncover cellular processes hijacked and/or altered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), providing promising therapeutic targets. The possibility to further validate putative key targets from high-confidence interactions between viral bait and host protein through follow-up MS-based multi-omics experiments offers an unprecedented opportunity in the drug discovery pipeline. In particular, drug repurposing, making use of already existing approved drugs directly targeting these identified and validated host interactors, might shorten the time and reduce the costs in comparison to the traditional drug discovery process. This route might be promising for finding effective antiviral therapeutic options providing a turning point in the fight against the coronavirus disease-2019 (COVID-19) outbreak.
【저자키워드】 COVID-19, Drug repurposing, SARS-CoV-2, proteomics, Antiviral, virus, protein–protein interaction, affinity-purification mass spectrometry, proximity-dependent biotin labeling (BioID), emerging, 【초록키워드】 coronavirus disease, coronavirus, mass spectrometry, Drug discovery, severe acute respiratory syndrome Coronavirus, Viral, outbreak, virus entry, target, targets, Follow-up, experiment, respiratory, therapeutic targets, cellular, Interaction, PPI, protein–protein interactions, therapeutic option, host cells, life cycle, host cell, high resolution, approved drug, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, help, host protein, viral life cycle, protein interactions, advent, cellular processes, Affinity purification, offer, mirage, virus–host interactions, Host, Generation, approach, effective, identify, regulated, reduce, cellular processe, virus–host interaction, 【제목키워드】 mass spectrometry, Therapeutics, interactome, affinity, mass, route, mapping, Spectrometry,